Related references
Note: Only part of the references are listed.Clinical and In Vitro Resistance of Plasmodium falciparum to Artesunate- Amodiaquine in Cambodia
Melissa Mairet-Khedim et al.
CLINICAL INFECTIOUS DISEASES (2021)
Triple Artemisinin-Based Combination Therapies for Malaria - A New Paradigm?
Rob W. van der Pluijm et al.
TRENDS IN PARASITOLOGY (2021)
Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial
Rob W. van der Pluijm et al.
LANCET (2020)
Emergence and clonal expansion of in vitro artemisinin-resistantPlasmodium falciparum kelch13R561H mutant parasites in Rwanda
Aline Uwimana et al.
NATURE MEDICINE (2020)
The past, present and future of anti-malarial medicines
Edwin G. Tse et al.
MALARIA JOURNAL (2019)
Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study
Rob W. van der Pluijm et al.
LANCET INFECTIOUS DISEASES (2019)
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance: the case against
Sanjeev Krishna
MALARIA JOURNAL (2019)
Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
Nicholas J. White
MALARIA JOURNAL (2019)
Drugs in Development for Malaria
Elizabeth A. Ashley et al.
DRUGS (2018)
Why the Best Interest Standard Is Not Self-Defeating, Too Individualistic, Unknowable, Vague or Subjective
Loretta M. Kopelman
AMERICAN JOURNAL OF BIOETHICS (2018)
When it just won't go away: oral artemisinin monotherapy in Nigeria, threatening lives, threatening progress
Chinazo Ujuju et al.
MALARIA JOURNAL (2017)
Private sector opportunities and threats to achieving malaria elimination in the Greater Mekong Subregion: results from malaria outlet surveys in Cambodia, the Lao PDR, Myanmar, and Thailand
Sochea Phok et al.
MALARIA JOURNAL (2017)
New developments in anti-malarial target candidate and product profiles
Jeremy N. Burrows et al.
MALARIA JOURNAL (2017)
Antimalarial Drug Resistance: A Threat to Malaria Elimination
Didier Menard et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Evidence of successful malaria case management policy implementation in Cambodia: results from national ACTwatch outlet surveys
Joe Novotny et al.
MALARIA JOURNAL (2016)
Antimalarial mass drug administration: ethical considerations
Phaik Yeong Cheah et al.
INTERNATIONAL HEALTH (2016)
What Can We Learn About the Processes of Regulation of Tuberculosis Medicines From the Experiences of Health Policy and System Actors in India, Tanzania, and Zambia?
Kabir Sheikh et al.
INTERNATIONAL JOURNAL OF HEALTH POLICY AND MANAGEMENT (2016)
Health Product Supply Chains in Developing Countries: Diagnosis of the Root Causes of Underperformance and an Agenda for Reform
Prashant Yadav
HEALTH SYSTEMS & REFORM (2015)
Motivations and perceptions of community advisory boards in the ethics of medical research: the case of the Thai-Myanmar border
Khin Maung Lwin et al.
BMC MEDICAL ETHICS (2014)
Artemisinin resistance - modelling the potential human and economic costs
Yoel Lubell et al.
MALARIA JOURNAL (2014)
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
E. A. Ashley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Is the Best Interest Standard Good for Pediatrics?
Rosamond Rhodes et al.
PEDIATRICS (2014)
Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa
Gaurvika M. L. Nayyar et al.
LANCET INFECTIOUS DISEASES (2012)
Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries
Kathryn A. O'Connell et al.
MALARIA JOURNAL (2011)
Monitoring fever treatment behaviour and equitable access to effective medicines in the context of initiatives to improve ACT access: baseline results and implications for programming in six African countries
Megan Littrell et al.
MALARIA JOURNAL (2011)
Poor quality vital anti-malarials in Africa - an urgent neglected public health priority
Paul N. Newton et al.
MALARIA JOURNAL (2011)
A major transition in malaria treatment: The adoption and deployment of artemisinin-based combination therapies
Andrea Bosman et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2007)
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
Abdinasir A. Amin et al.
MALARIA JOURNAL (2007)
The costs of changing national policy: lessons from malaria treatment policy guidelines in Tanzania
JA Mulligan et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2006)
Treatment of paediatric malaria during a period of drug transition to artemether-lumefantrine in Zambia: cross sectional study
D Zurovac et al.
BRITISH MEDICAL JOURNAL (2005)
The process of changing national malaria treatment policy: lessons from country-level studies
HA Williams et al.
HEALTH POLICY AND PLANNING (2004)
Share Paper
